Equities

Raia Drogasil S/A

Raia Drogasil S/A

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (BRL)26.04
  • Today's Change0.67 / 2.64%
  • Shares traded2.60m
  • 1 Year change-8.31%
  • Beta0.6122
Data delayed at least 15 minutes, as of Nov 22 2024 19:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in BRLIncome statement in BRLView more

Year on year Raia Drogasil S/A grew revenues 16.88% from 29.07bn to 33.97bn while net income improved 5.91% from 996.11m to 1.05bn.
Gross margin29.83%
Net profit margin3.02%
Operating margin6.19%
Return on assets5.51%
Return on equity18.47%
Return on investment9.39%
More ▼

Cash flow in BRLView more

In 2023, Raia Drogasil S/A did not generate a significant amount of cash. However, the company earned 1.79bn from its operations for a Cash Flow Margin of 5.26%. In addition the company used 1.31bn on investing activities and also paid 499.42m in financing cash flows.
Cash flow per share1.77
Price/Cash flow per share14.76
Book value per share3.67
Tangible book value per share2.51
More ▼

Balance sheet in BRLView more

Raia Drogasil S/A has a Debt to Total Capital ratio of 54.90%, a lower figure than the previous year's 99.64%.
Current ratio1.39
Quick ratio0.5117
Total debt/total equity1.22
Total debt/total capital0.549
More ▼

Growth rates in BRL

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 24.43% and 6.24%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Grocery) industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.86%
Div growth rate (5 year)20.02%
Payout ratio (TTM)46.83%
EPS growth(5 years)15.98
EPS (TTM) vs
TTM 1 year ago
6.40
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.